Fibrin Glue Sac Filling for Preventing Type II Endoleak,Short-Term Outcomes of a Prospective Randomized Controlled Trial

Abstract

Objective:

Type II endoleak (T2EL) worsens the long-term results of endovascular aneurysm repair (EVAR). How to prevent T2ELs remains controversial. This study aimed to evaluate the efficacy and safety of fibrin glue sac filling (FGSF) to prevent T2ELs after EVAR.

Methods:

A prospective randomized controlled trial was conducted. Patients were randomly divided into group A (standard EVAR + FGSF) and group B (standard EVAR). The follow-up plans included outpatient or telephone consultation at 1 and 3 months and computed tomography (CT) angiography at 6 months, 1 year, and once a year after EVAR.

Results:

A total of 64 abdominal aortic aneurysm (AAA) patients were randomized to the 2 groups. All patients were followed up for more than 6 months. The 2 groups showed similar baseline characteristics. The rate of T2ELs on immediate angiography in group A (9.6%) was significantly lower than that in group B (33.3%, p=0.033). Moreover, the sac area change was significantly reduced in group A at 6 months after EVAR (p=0.021). However, T2EL incidence was similar at the 6-month (p=0.055) and 1-year (p=0.057) follow-ups, and AAA diameter change was also similar at 1 year. There were similar operation times, radiation doses, severe adverse events (SAEs), and reinterventions between the 2 groups.

Conclusion:

Fibrin glue sac filling could prevent short-term type II endoleaks and promote AAA shrinkage after 6 months. The FGSF procedure is swift and straightforward; however, patients are at risk of bowel ischemia, especially after previous bowel resections or concomitant superior mesenteric artery (SMA) disease.

Clinical Impact

Standard endovascular aneurysm repair (EVAR) couldn’t prevent type II endoleak (T2EL). In this study, we found fibrin glue sac filling (FGSF) could prevent T2EL and promote AAA shrinkage in a short term. And the FGSF procedure is easy, it will be a useful supplement to standard EVAR for clinicians. And FGSF might have potential usefulness on ruptured aneurysms, although without direct evidence.Fibrin glue is often used to hemostasis and tissue adhesion in surgical patients and burn patients, we firstly carry out a randomized controlled study and prove that fibrin glue sac filling could prevent T2EL and promote sac remodeling.

Keywords

abdominal aortic aneurysm endovascular aneurysm repair fibrin glue type II endoleak randomized trial

Get full access to this article

View all access options for this article.

References

Ultee

KHJ

Büttner

Huurman

, et al. Systematic review and meta-analysis of the outcome of treatment for type II endoleak following endovascular aneurysm repair. Eur J Vasc Endovasc Surg. 2018;56(6):794–807. doi:10.1016/j.ejvs.2018.06.009.

Chaikof

Dalman

Eskandari

, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67:2–77.e2. doi:10.1016/j.jvs.2017.10.044.

Jones

Atkins

Brewster

, et al. Persistent type 2 endoleak after endovascular repair of abdominal aortic aneurysm is associated with adverse late outcomes. J Vasc Surg. 2007;46:1–8. doi:10.1016/j.jvs.2007.02.073.

Seike

Matsuda

Shimizu

, et al. Nationwide analysis of persistent type II endoleak and late outcomes of endovascular abdominal aortic aneurysm repair in Japan: a propensity-matched analysis. Circulation. 2022;145:1056–1066. doi:10.1161/circulationaha.121.056581.

Baum

Carpenter

Golden

, et al. Treatment of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms: comparison of transarterial and translumbar techniques. J Vasc Surg. 2002;35(1):23–29. doi:10.1067/mva.2002.121068.

Haulon

Tyazi

Willoteaux

, et al. Embolization of type II endoleaks after aortic stent-graft implantation: technique and immediate results. J Vasc Surg. 2001;34(4):600–605. doi:10.1067/mva.2001.117888.

Uthoff

Katzen

Gandhi

, et al. Direct percutaneous sac injection for postoperative endoleak treatment after endovascular aortic aneurysm repair. J Vasc Surg. 2012;56(4):965–972. doi:10.1016/j.jvs.2012.03.269.

Chung

Morgan

RA.

Type 2 endoleaks post-EVAR: current evidence for rupture risk, intervention and outcomes of treatment. Cardiovasc Intervent Radiol. 2015;38(3):507–522. doi:10.1007/s00270-014-0987-x.

Samura

Morikage

Otsuka

, et al. Endovascular aneurysm repair with inferior mesenteric artery embolization for preventing type II endoleak: a prospective randomized controlled trial. Ann Surg. 2020;271(2):238–244. doi:10.1097/sla.0000000000003299.

10.

Piazza

Squizzato

Zavatta

, et al. Outcomes of endovascular aneurysm repair with contemporary volume-dependent sac embolization in patients at risk for type II endoleak. J Vasc Surg. 2016;63(1):32–38. doi:10.1016/j.jvs.2015.08.049.

11.

Pilon

Tosato

Danieli

, et al. Intrasac fibrin glue injection after platinum coils placement: the efficacy of a simple intraoperative procedure in preventing type II endoleak after endovascular aneurysm repair. Interact Cardiovasc Thorac Surg. 2010;11(1):78–82. doi:10.1510/icvts.2009.231167.

12.

Zhang

Zhao

, et al. Long-term outcome of sac filling with fibrin sealant after endovascular aneurysm repair of abdominal aortic aneurysm with challenging aortic neck anatomy. J Vasc Surg. 2019;70:471–477. doi:10.1016/j.jvs.2018.10.113.

13.

Xia

Song

Zhang

, et al. Endovascular treatment with in-vitro fenestration and sac filling technique for ruptured thoracoabdominal aortic aneurysm with Behcet’s disease. J Cardiothorac Surg. 2020;15:221. doi:10.1186/s13019-020-01252-6.

14.

Natrella

Rapellino

Navarretta

, et al. Embo-EVAR: a technique to prevent type II endoleak? a single-center experience. Ann Vasc Surg. 2017;44:119–127. doi:10.1016/j.avsg.2017.01.028.

15.

Ronsivalle

Faresin

Franz

, et al. Aneurysm sac “thrombization” and stabilization in EVAR: a technique to reduce the risk of type II endoleak. J Endovasc Ther. 2010;17:517–524. doi:10.1583/09-3004.1.

16.

Fujimura

Matsubara

Takahara

, et al. Early sac shrinkage is a good surrogate marker of durable success after endovascular aneurysm repair in Japanese patients. J Vasc Surg. 2018;67:1410–1418.e1. doi:10.1016/j.jvs.2017.08.076.

17.

Fabre

Mougin

Mitilian

, et al. Prospective, randomised two centre study of endovascular repair of abdominal aortic aneurysm with or without sac embolisation. Eur J Vasc Endovasc Surg. 2021;61:201–209. doi:10.1016/j.ejvs.2020.11.028.

18.

Zanchetta

Faresin

Pedon

, et al. Intraoperative intrasac thrombin injection to prevent type II endoleak after endovascular abdominal aortic aneurysm repair. J Endovasc Ther. 2007;14:176–183. doi:10.1177/152660280701400209.

19.

Gambaro

Abou-Zamzam

Jr Teruya

, et al. Ischemic colitis following translumbar thrombin injection for treatment of endoleak. Ann Vasc Surg. 2004;18(1):74–78. doi:10.1007/s10016-003-0102-2.

20.

Ward

Cohen

Fischman

, et al. Preoperative inferior mesenteric artery embolization before endovascular aneurysm repair: decreased incidence of type II endoleak and aneurysm sac enlargement with 24-month follow-up. J Vasc Interv Radiol. 2013;24(1):49–55. doi:10.1016/j.jvir.2012.09.022.